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We aimed to determine whether patients with subclinical hyperthyroidism (SH) are subject to oxidative stress. Twenty-two women
and 8 men having endogenous subclinical hyperthyroidism for a duration of at least 6 months, and 21 women and 9 men healthy
controlswereincludedinthisstudy.Wemeasuredthelevelofplasmamalondialdehyde,asoneofthelipidperoxidationmarkers,and
the activity of erythrocyte superoxide dismutase, which is an antioxidant enzyme. The activity of erythrocyte superoxide dismutase
and plasma malondialdehyde levels were found to be signiﬁcantly higher in subjects with subclinical hyperthyroidism than the
control group (P<. 01). The results of this study suggest that oxidative stress and antioxidative response could be increased in
patients having subclinical hyperthyroidism.
INTRODUCTION
Aerobic organisms possess antioxidant defense sys-
tems that deal with reactive oxygen species (ROS) as a
result of aerobic respiration substrate oxidation. ROS,
including hydroxyl radicals (OH·), superoxide anions
(O2
·−), and hydrogen peroxide (H2O2), are generated in
response to external and internal stimuli. Low levels of
ROS are necessary for several biological processes includ-
ing intracellular diﬀerentiation and cell progression or ar-
rest of apoptosis growth, immunity, and defense against
microorganisms. In contrast, high doses and/or inade-
quateremovalofROSresultinoxidativestress,whichmay
cause damage to biological macromolecules [1].
Lipid peroxidation is a normal phenomenon that oc-
curs continuously at low levels in every individual. Those
peroxidation reactions are toxic to cells and cell mem-
branes; however, they are normally controlled by coun-
tervailing biological mechanisms. Severe oxidative stress
produces ROS and induces uncontrolled lipid peroxi-
dation. Following lipid peroxidation aldehydic products,
such as free fatty acids, malondialdehyde (MDA), occur
and those products are referred to as thiobarbituric acid-
reacting substances. Since the cell membranes consist pri-
marilyoflipids,uncontrolledlipidperoxidationcancause
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cell injury and death via DNA damage and directly in-
hibiting proteins, such as Na+/K-ATPases and glutamate
transporters [2]. The protecting feature of SOD, one of
the antioxidant enzymes, against oxidative stress bears an
essential role for life [3].
Subclinical hyperthyroidism (SH) is characterised by
reducedserumthyrotrophin(TSH)levelsdespitefreethy-
roxine (FT4) and free triiodothyronine (FT3)e s t i m a t e s
within the reference range, in subjects with no obvious
symptoms of hyperthyroidism. It has been reported that
hyperthyroidism leads to a hypermetabolic state and ac-
celerates free radical production to induce changes in an-
tioxidant enzyme activities. However, to our knowledge,
there is no study in the literature about the role of oxida-
tive stress in SH. For that reason, we aimed to investigate
if there is any relation between the increase in oxidative
stress and SH.
MATERIALS AND METHODS
Twenty-two women and 8 men having endogenous
SH for a duration of at least 6 months, with an age
range of 26–68 years (mean: 42.16 ± 9.69 years), and
21 women and 9 men healthy controls having an age
range of 29–65 years (mean: 40.96 ± 7.69 years) were
included in this study. All subclinical hyperthyroid pa-
tients were presented with multinodular goitre as evalu-
ated by scintigraphy and ultrasound. None of the patients
or control subjects had diabetes mellitus, pituitary and
other acute or chronic systemic diseases. Also, none of the
patients were taking L-tiroxine or antithyroid drugs for58 Ali Cetinkaya et al 2005:1 (2005)
Table 1. Laboratory ﬁndings in patients with subclinical hyperthyroidism and control group. NS (not signiﬁcant); Hb,
(haemoglobin).
Variable Patients with SH Control group P
TT3 (IU/mL) 1.44 ±0.38 1.37 ±0.24 NS
TT4 (ng/mL) 9.06 ±1.42 9.07 ±1.20 NS
FT3 (pg/dL) 4.28 ±0.97 4.13 ±0.67 NS
FT4 (ng/dL) 0.71 ±0.11 0.73 ±0.17 NS
TSH (mIU/mL) 0.09 ±0.08 1.61 ±0.65 <. 01
MDA (nmol/L) 3.34 ±0.50 2.12 ±0.26 <. 01
SOD (U/gHb) 3042.33 ±908.03 2024.70 ±501.11 <. 01
hyperthyroidism. Written consent was obtained from all
patients after giving them information about the study.
Free T3 (FT3), total T3 (TT3), free T4 (FT4), total
T4 (TT4), and ultrasensitive TSH were measured with
Immulite 2000 by the immunoassay method. Erythrocyte
SOD activity was measured according to the method de-
scribed by Fridovich [4]. SOD activity was expressed as
U/gHb. Plasma MDA was measured according to proce-
dure of Ohkawa et al [5]. MDA level was expressed as
nmol/mL.
Statistical analysis was carried out with the SPSS-X
(Release 4.1) programme. All data were expressed as the
mean ± SD. The control and patient groups for each pa-
rameter were compared with Student t test. Diﬀerences
were considered signiﬁcant when P<. 05.
RESULTS
The average activity of SOD in patients with SH was
3042.33±908.03 while it was 2024.70±501.11 in the con-
trol group (P<. 01). The level of MDA in patients with
SH was 3.34 ± 0.50 while it was 2.12 ± 0.26 in the control
group (P<. 01). These data and thyroid hormone levels
are presented in Table 1.
DISCUSSION
Recently, increasing experimental and clinical studies
have shown that free radicals play a role in the etiology
of many illnesses. Similarly the importance of oxidative
process in the beginning of tissue damage due to hyper-
thyroidism has been demonstrated. It has been demon-
strated that increased production of free oxygen radicals
is especially seen in microsomal fraction of the liver in ex-
perimentally hyperthyroid rats. It has been thought that
the increase in lipid peroxide levels is originated from the
impairment of the polyunsaturated fatty acids due to free
radical oxidation.
In the recent studies systemic eﬀects of SH have been
shown to be as in clinical hyperthyroidism. Some stud-
i e sh a v ep u tf o r w a r dt h a tS Hh a se ﬀects such as increased
cardiac disorders, decrease in the quality of life, and caus-
ing mortality. Also, there are studies showing that SH in-
creases the risk of bone loss, dementia, and Alzheimer’s
disease. Although many experimental and clinical inves-
tigations have been conducted about oxidative stress and
antioxidantcapacityinhyperthyroidism,wewerenotable
to ﬁnd any relevant data in electronic databases about SH.
There is a controversy whether hyperthyroidism is as-
sociated with an increase or decrease in the activities of
antioxidant enzymes. It is reported that SOD activity was
increased in the cardiac muscle and liver in hyperthyroid
rats [6]. Also, the increase of SOD have been shown in the
blood of patients with hyperthyroidism. On the contrary,
some investigators found decreased SOD activity in the
blood samples of patients with hyperthyroidism [7].
WespeculatethatSHgivesrisetooxidativestress,then
high levels of free radicals inside the cells increase the
MDA levels and the organism defends itself against the
eﬀects of oxidative stress by increasing SOD activity as a
protection mechanism. In our study we measured more
statistically signiﬁcant SOD activity in the subclinical hy-
perthyroid group than in the control group. This suggests




idence to support the protective role of SOD against per-
oxidation.
In conclusion, the oxidative stress associated with
SH may play an important role in the systemic ef-
fects and progression to hyperthyroidism. Further large-
population-baseddetailedstudiestounderstandoxidative
stress and antioxidant capacity in SH are needed to deter-
mine these interactions.
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